Entry Point Capital, LLC Sutro Biopharma, Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 69,678 shares of STRO stock, worth $211,821. This represents 0.35% of its overall portfolio holdings.
Number of Shares
69,678Holding current value
$211,821% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
122Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$17.6 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$17.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$14.4 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$12.5 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$9.19 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $159M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...